Terms: = Lung cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
5149 results:
1. Response- and Progression-Based End Points in Trial and Observational Cohorts of Patients With NSCLC.
Lu Y; Langerman SS; McCain E; Magee K; Maund SL; Srivastava MK; Samant M
JAMA Netw Open; 2024 May; 7(5):e249286. PubMed ID: 38700864
[TBL] [Abstract] [Full Text] [Related]
2. Role of antihypertensive medicines in prostate cancer: a systematic review.
Iheanacho CO; Enechukwu OH
BMC Cancer; 2024 Apr; 24(1):542. PubMed ID: 38684963
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma].
Mei W; Wang XM; Liu RA; Xiong W; Zhang YP
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):258-267. PubMed ID: 38677988
[No Abstract] [Full Text] [Related]
4. A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.
Sun R; Ning Z; Qin H; Zhang W; Teng Y; Jin C; Liu J; Wang A
Sci Rep; 2024 Apr; 14(1):9552. PubMed ID: 38664423
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
6. Recording and classifying met receptor mutations in cancers.
Guérin C; Tulasne D
Elife; 2024 Apr; 13():. PubMed ID: 38652103
[TBL] [Abstract] [Full Text] [Related]
7. Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort study.
Resova K; Knybel L; Parackova T; Rybar M; Cwiertka K; Cvek J
Radiat Oncol; 2024 Apr; 19(1):50. PubMed ID: 38637844
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic Performance of MRI for the Detection of Pulmonary Nodules: A Systematic Review and meta-Analysis.
Cavion CC; Altmayer S; Forte GC; Feijó Andrade RG; Hochhegger DQDR; Zaguini Francisco M; Camargo C; Patel P; Hochhegger B
Radiol Cardiothorac Imaging; 2024 Apr; 6(2):e230241. PubMed ID: 38634743
[TBL] [Abstract] [Full Text] [Related]
9. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell lung cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Illini O; Saalfeld FC; Christopoulos P; Duruisseaux M; Vikström A; Peled N; Demedts I; Dudnik E; Eisert A; Hashemi SMS; Janzic U; Kian W; Mohorcic K; Mohammed S; Silvoniemi M; Rothschild SI; Schulz C; Wesseler C; Addeo A; Armster K; Itchins M; Ivanović M; Kauffmann-Guerrero D; Koivunen J; Kuon J; Pavlakis N; Piet B; Sebastian M; Velthaus-Rusik JL; Wannesson L; Wiesweg M; Wurm R; Albers-Leischner C; Aust DE; Janning M; Fabikan H; Herold S; Klimova A; Loges S; Sharapova Y; Schütz M; Weinlinger C; Valipour A; Overbeck TR; Griesinger F; Jakopovic M; Hochmair MJ; Wermke M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612799
[TBL] [Abstract] [Full Text] [Related]
10. Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.
Kumbrink J; Demes MC; Jeroch J; Bräuninger A; Hartung K; Gerstenmaier U; Marienfeld R; Hillmer A; Bohn N; Lehning C; Ferch F; Wild P; Gattenlöhner S; Möller P; Klauschen F; Jung A
Pathol Oncol Res; 2024; 30():1611590. PubMed ID: 38605929
[TBL] [Abstract] [Full Text] [Related]
11. Targeted therapeutic options in early and metastatic NSCLC-overview.
Gálffy G; Morócz É; Korompay R; Hécz R; Bujdosó R; Puskás R; Lovas T; Gáspár E; Yahya K; Király P; Lohinai Z
Pathol Oncol Res; 2024; 30():1611715. PubMed ID: 38605928
[TBL] [Abstract] [Full Text] [Related]
12. CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor-Mutated Non-Small Cell lung cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report.
Al-Obeidi E; Kelly K; Gandara DR; Riess JW
JCO Precis Oncol; 2024 Apr; 8():e2300677. PubMed ID: 38603654
[TBL] [Abstract] [Full Text] [Related]
13. [Clinical characteristics and prognosis analysis of pulmonary sarcomatoid carcinoma].
Feng XY; Chen MJ; Xu Y; Zhong W; Liu XY; Gao XX; Zhao J; Wang MZ
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):319-324. PubMed ID: 38599806
[No Abstract] [Full Text] [Related]
14. High CASC expression predicts poor prognosis of lung cancer: A systematic review with meta-analysis.
Han H; Huang H; Chen AP; Tang Y; Huang X; Chen C
PLoS One; 2024; 19(4):e0292726. PubMed ID: 38573879
[TBL] [Abstract] [Full Text] [Related]
15. Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.
Murakami S; Shinada K; Otsutsumi Y; Komine F; Yuan Y; Nakamura J; Katakura S; Kondo T; Kato T; Yokose T; Saito H
Cancer Med; 2024 Apr; 13(7):e7162. PubMed ID: 38572952
[TBL] [Abstract] [Full Text] [Related]
16. Mesothelin promotes brain metastasis of non-small cell lung cancer by activating met.
Xia S; Duan W; Xu M; Li M; Tang M; Wei S; Lin M; Li E; Liu W; Wang Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):103. PubMed ID: 38570866
[TBL] [Abstract] [Full Text] [Related]
17. The contribution of estimated dead space fraction to mortality prediction in patients with chronic obstructive pulmonary disease-a new proposal.
Chuang ML; Wang YH; Lin IF
PeerJ; 2024; 12():e17081. PubMed ID: 38560478
[TBL] [Abstract] [Full Text] [Related]
18. Patterns and treatment outcomes of primary bone tumors in children treated at tertiary referral hospital, Ethiopia.
Lingerih T; Yeshiwas S; Mohamedsaid A; Arega G
BMC Cancer; 2024 Mar; 24(1):394. PubMed ID: 38549062
[TBL] [Abstract] [Full Text] [Related]
19. Assessing the Global Impact of Ambient Air Pollution on cancer Incidence and Mortality: A Comprehensive meta-Analysis.
Ramamoorthy T; Nath A; Singh S; Mathew S; Pant A; Sheela S; Kaur G; Sathishkumar K; Mathur P
JCO Glob Oncol; 2024 Mar; 10():e2300427. PubMed ID: 38513187
[TBL] [Abstract] [Full Text] [Related]
20. Mobocertinib: Mechanism of action, clinical, and translational science.
Hanley MJ; Camidge DR; Fram RJ; Gupta N
Clin Transl Sci; 2024 Mar; 17(3):e13766. PubMed ID: 38511563
[TBL] [Abstract] [Full Text] [Related]
[Next]